Premium
Antimuscarinic properties of vamicamide, a novel compound for the treatment of pollakiuria
Author(s) -
Yamamoto Takao,
Matsuo Masahiko,
Yamazaki Shunji,
Ueshima Koji,
Sawada Tadashi,
Furuichi Atsuko,
Ozaki Reiko,
Nishii Misako,
Miura Shintaro,
Kusunoki Takahiro,
Sato Natsuki,
Koibuchi Yasushi,
Esumi Kimio,
Ohtsuka Minoru
Publication year - 1995
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/ddr.430340103
Subject(s) - carbachol , chemistry , dissociation constant , endocrinology , medicine , muscarinic acetylcholine receptor , stimulation , receptor , guinea pig , urinary bladder , in vivo , detrusor muscle , biology , biochemistry , microbiology and biotechnology
The antimuscarinic profile of vamicamide, a novel compound for the treatment of pollakiuria, was investigated in both in vitro and in vivo preparations. Vamicamide (10 nM–10 μM) inhibited the contractile response of isolated guinea‐pig detrusor muscle to transmural electrical stimulation. In isolated guinea‐pig detrusor muscle, vamicamide also inhibited contractile response to carbachol with an IC 50 value of 0.71 μM, whereas it had little or no effect on detrusor contractions induced by KCl, BaCl 2 , or α, β‐methylene ATP. In binding studies with dog membrane preparations, the dissociation constant (Ki) of vamicamide against tritiated N‐methylscopolamine ([ 3 H]NMS) binding was 172 ± 8 nM for the urinary bladder, which was lower ( P < 0.01) than those for the heart (322 ± 31 nM), stomach (317 ± 29 nM), and salivary gland (321 ± 32 nM). The Ki value for the cerebral cortex (95 ± 4 nM) tended to be lower than that for the urinary bladder. In binding studies with cloned human muscarinic receptor subtypes (m1–m3), the dissociation constant (Ki) of vamicamide against [ 3 H]NMS binding was 89.0 ± 3.5 nM for the m3 receptor subtype, which was lower than those for the m1 (235 ± 5 nM, P < 0.05) and m2 (593 ± 49 nM, P < 0.01) receptor subtypes. In anesthetized dogs, vamicamide (3.2–100 μg/kg; 11–336 nmol/kg, iv) inhibited the carbachol‐induced contractile responses of the urinary bladder with an ID 50 value of 16.1 μg/kg (54 nmol/kg), the stomach with a value of 31.3 μg/kg (105 nmol/kg), the descending colon with a value of 10.1 μg/kg (34 nmol/kg), and secretory response of the salivary gland to carbachol with a value of 43.3 μg/kg (146 nmol/kg); the inhibitory effects of the compound on the stomach and salivary gland were weaker ( P < 0.01) than that on the urinary bladder. Furthermore, duration of the action of vamicamide was longer on the urinary bladder and descending colon than those on the stomach and salivary gland. These results suggest that vamicamide has a selective binding affinity to the muscarinic m3 receptor subtype and exhibits greater and longer inhibitory action on the urinary bladder than the other organs examined. © Wiley‐Liss, Inc.